WILLIMANTIC, Conn., April 17, 2018 -- The Board of Directors of SI Financial Group, Inc. (the “Company”) (NASDAQ:SIFI) has declared a cash dividend on the Company’s outstanding shares of common stock. The dividend of $0.06 per share will be paid on May 29, 2018 to stockholders of record as of the close of business on May 7, 2018.
SI Financial Group, Inc. is the holding company for Savings Institute Bank and Trust Company. Established in 1842, the Savings Institute Bank and Trust Company is a community-oriented financial institution headquartered in Willimantic, Connecticut.
CONTACT:
Catherine R Pomerleau
Executive Assistant / Investor Relations Administrator
Phone: (860) 456-6514 / Email: [email protected]


U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase
How Marco Pharma International Preserves German Homeopathic Traditions in America
Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth
FTC Questions Apple News Over Alleged Bias Against Conservative Media
Grok AI Market Share Surges as xAI Faces Scrutiny Over Image Generation Controversy
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions
Lockheed Martin Secures $101M in U.S. Defense Contracts for AEGIS, F-35, and Missile Systems
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
Anduril Eyes $60 Billion Valuation in New Funding Round to Expand Defense Manufacturing and Autonomous Fighter Jet Development
Sachem Head Boosts Warner Bros. Discovery Stake Amid Netflix Deal and Paramount Bid
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval 



